000 | 01578 a2200433 4500 | ||
---|---|---|---|
005 | 20250516104708.0 | ||
264 | 0 | _c20130321 | |
008 | 201303s 0 0 eng d | ||
022 | _a1875-533X | ||
024 | 7 |
_a10.2174/092986712803306466 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGiannubilo, S R | |
245 | 0 | 0 |
_aAnticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia. _h[electronic resource] |
260 |
_bCurrent medicinal chemistry _c2012 |
||
300 |
_a4562-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aAspirin _xadverse effects |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 | _aBreast Feeding |
650 | 0 | 4 |
_aChondroitin Sulfates _xadverse effects |
650 | 0 | 4 |
_aDermatan Sulfate _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFondaparinux |
650 | 0 | 4 |
_aHeparin _xadverse effects |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadverse effects |
650 | 0 | 4 |
_aHeparitin Sulfate _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aPolysaccharides _xadverse effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xdrug therapy |
650 | 0 | 4 |
_aThromboembolism _xdrug therapy |
650 | 0 | 4 |
_aThrombophilia _xetiology |
650 | 0 | 4 |
_aWarfarin _xadverse effects |
700 | 1 | _aTranquilli, A L | |
773 | 0 |
_tCurrent medicinal chemistry _gvol. 19 _gno. 27 _gp. 4562-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986712803306466 _zAvailable from publisher's website |
999 |
_c22011242 _d22011242 |